Patel M V, Mueller T, Lee S K. "Method for the Synthesis of Valganciclovir EP Impurity Q Isomer" [P]. US Patent, US 10806829 B2, 2021-09-17.
发明人杨光,唐晓军,沈红梅. "A Process for Preparing High-Purity Valganciclovir EP Impurity Q Isomer" [P]. 中国发明专利, 专利号 CN 110679819 B, 授权公告日 2022-11-12.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 缬更昔洛韦EP杂质Q异构体 in Pharmaceutical Formulations". J. Sep. Sci., 2015, 1171, 4495-4511.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 缬更昔洛韦EP杂质Q异构体 as an Impurity". Anal. Chim. Acta, 2010, 1181, 2284-2288.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Valganciclovir EP Impurity Q Isomer Using HRMS and NMR". Biomed. Chromatogr., 2024, 2443, (12), 5857-5882.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 缬更昔洛韦EP杂质Q异构体 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2017, 2460, (8), 2381-2394.